The confluence of sex hormones and aging on immunity

Frontiers in Immunology

Volumn 9, Issue JUN, 2018, Pages

  Bupp, Melanie R Gubbels ^a   Potluri, Tanvi ^b   Fink, Ashley L ^b   Klein, Sabra L ^b  

^a RANDOLPH MACON COLLEGE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autoimmunity; Cancer; Checkpoint blockade; Immunity; Immunotherapy; Sex; Sex hormones; Vaccines

Indexed keywords

SEX HORMONE; VACCINE;

ADAPTIVE IMMUNITY; AGING; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CARCINOGENESIS; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MALIGNANT NEOPLASM; NONHUMAN; REVIEW; SEX DIFFERENCE; VACCINATION;

EID: 85048092728     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.01269     Document Type: Review

References (269)

1. Ortman JM, VelkoffVA, Hogan H. An aging nation: the older population in the United States. Current Population Reports. Washington, DC: U.S. Census Bureau (2014)
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 380(9859):2095-128. doi:10.1016/S0140-6736(12)61728-0
3. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 385(9963):117-71. doi:10.1016/S0140-6736(14)61682-2
4. Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol (2014) 30(1):16-22. doi:10.3109/09513590.2013.852531
5. Cannizzo ES, Clement CC, Sahu R, Follo C, Santambrogio L. Oxidative stress, inflamm-aging and immunosenescence. J Proteomics (2011) 74(11):2313-23. doi:10.1016/j.jprot.2011.06.005
6. Agrawal A, Tay J, Ton S, Agrawal S, Gupta S. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J Immunol (2009) 182(2):1138-45. doi:10.4049/jimmunol.182.2.1138
7. Canan CH, Gokhale NS, Carruthers B, Lafuse WP, Schlesinger LS, Torrelles JB, et al. Characterization of lung inflammation and its impact on macrophage function in aging. J Leukoc Biol (2014) 96(3):473-80. doi:10.1189/jlb.4A0214-093RR
8. Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, Deng Y. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol (2009) 70(10):777-84. doi:10.1016/j.humimm.2009.07.005
9. Wenisch C, Patruta S, Daxbock F, Krause R, Horl W. Effect of age on human neutrophil function. J Leukoc Biol (2000) 67(1):40-5. doi:10.1002/jlb.67.1.40
10. Haynes L, Maue AC. Effects of aging on T cell function. Curr Opin Immunol (2009) 21(4):414-7. doi:10.1016/j.coi.2009.05.009
11. Miller JP, Cancro MP. B cells and aging: balancing the homeostatic equation. Exp Gerontol (2007) 42(5):396-9. doi:10.1016/j.exger.2007.01.010
12. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A (2003) 100(25):15053-8. doi:10.1073/pnas.2433717100
13. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol (2004) 173(1):673-81. doi:10.4049/jimmunol.173.1.673
14. Gubbels Bupp MR. Sex, the aging immune system, and chronic disease. Cell Immunol (2015) 294(2):102-10. doi:10.1016/j.cellimm.2015.02.002
15. Hearps AC, Martin GE, Angelovich TA, Cheng WJ, Maisa A, Landay AL, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell (2012) 11(5):867-75. doi:10.1111/j.1474-9726.2012.00851.x
16. Puchta A, Naidoo A, Verschoor CP, Loukov D, Thevaranjan N, Mandur TS, et al. TNF drives monocyte dysfunction with age and results in impaired anti-pneumococcal immunity. PLoS Pathog (2016) 12(1):e1005368. doi:10.1371/journal.ppat.1005368
17. Verschoor CP, Johnstone J, Millar J, Parsons R, Lelic A, Loeb M, et al. Alterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly. PLoS One (2014) 9(8):e104522. doi:10.1371/journal.pone.0104522
18. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol (2007) 178(11):6912-22. doi:10.4049/jimmunol.178.11.6912
19. Moretto MM, Lawlor EM, Khan IA. Aging mice exhibit a functional defect in mucosal dendritic cell response against an intracellular pathogen. J Immunol (2008) 181(11):7977-84. doi:10.4049/jimmunol.181.11.7977
20. Stout-Delgado HW, Yang X, Walker WE, Tesar BM, Goldstein DR. Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J Immunol (2008) 181(10):6747-56. doi:10.4049/jimmunol.181.10.6747
21. Pereira LF, de Souza AP, Borges TJ, Bonorino C. Impaired in vivo CD4+ T cell expansion and differentiation in aged mice is not solely due to T cell defects: decreased stimulation by aged dendritic cells. Mech Ageing Dev (2011) 132(4):187-94. doi:10.1016/j.mad.2011.03.005
22. Li G, Smithey MJ, Rudd BD, Nikolich-Zugich J. Age-associated alterations in CD8alpha+ dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium. Aging Cell (2012) 11(6):968-77. doi:10.1111/j.1474-9726.2012.00867.x
23. Chougnet CA, Thacker RI, Shehata HM, Hennies CM, Lehn MA, Lages CS, et al. Loss of phagocytic and antigen cross-presenting capacity in aging dendritic cells is associated with mitochondrial dysfunction. J Immunol (2015) 195(6):2624-32. doi:10.4049/jimmunol.1501006
24. Grolleau-Julius A, Garg MR, Mo R, Stoolman LL, Yung RL. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8alpha-dendritic cell function. J Gerontol A Biol Sci Med Sci (2006) 61(10):1039-47. doi:10.1093/gerona/61.10.1039
25. Wong CP, Magnusson KR, Ho E. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp Gerontol (2010) 45(2):163-9. doi:10.1016/j.exger.2009.11.005
26. Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 203(10):1415-24. doi:10.1093/infdis/jir048
27. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 184(5):2518-27. doi:10.4049/jimmunol.0901022
28. Tesar BM, Walker WE, Unternaehrer J, Joshi NS, Chandele A, Haynes L, et al. Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell (2006) 5(6):473-86. doi:10.1111/j.1474-9726.2006.00245.x
29. Jones SC, Brahmakshatriya V, Huston G, Dibble J, Swain SL. TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism. J Immunol (2010) 185(11):6783-94. doi:10.4049/jimmunol.0901296
30. Zhao J, Zhao J, Legge K, Perlman S. Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest (2011) 121(12):4921-30. doi:10.1172/JCI59777
31. Grolleau-Julius A, Harning EK, Abernathy LM, Yung RL. Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res (2008) 68(15):6341-9. doi:10.1158/0008-5472.CAN-07-5769
32. Tan SY, Cavanagh LL, d'Advigor W, Shackel N, Fazekas de St Groth B, Weninger W. Phenotype and functions of conventional dendritic cells are not compromised in aged mice. Immunol Cell Biol (2012) 90(7):722-32. doi:10.1038/icb.2011.104
33. Shaw AC, Panda A, Joshi SR, Qian F, Allore HG, Montgomery RR. Dysregulation of human toll-like receptor function in aging. Ageing Res Rev (2011) 10(3):346-53. doi:10.1016/j.arr.2010.10.007
34. Sapey E, Greenwood H, Walton G, Mann E, Love A, Aaronson N, et al. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood (2014) 123(2):239-48. doi:10.1182/blood-2013-08-519520
35. Brubaker AL, Rendon JL, Ramirez L, Choudhry MA, Kovacs EJ. Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age. J Immunol (2013) 190(4):1746-57. doi:10.4049/jimmunol.1201213
36. Tseng CW, Kyme PA, Arruda A, Ramanujan VK, Tawackoli W, Liu GY. Innate immune dysfunctions in aged mice facilitate the systemic dissemination of methicillin-resistant S. aureus. PLoS One (2012) 7(7):e41454. doi:10.1371/journal.pone.0041454
37. Alonso-Fernandez P, Puerto M, Mate I, Ribera JM, de la Fuente M. Neutrophils of centenarians show function levels similar to those of young adults. J Am Geriatr Soc (2008) 56(12):2244-51. doi:10.1111/j.1532-5415.2008.02018.x
38. Hazeldine J, Harris P, Chapple IL, Grant M, Greenwood H, Livesey A, et al. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals. Aging Cell (2014) 13(4):690-8. doi:10.1111/acel.12222
39. McLachlan JA, Serkin CD, Morrey-Clark KM, Bakouche O. Immunological functions of aged human monocytes. Pathobiology (1995) 63(3):148-59. doi:10.1159/000163946
40. De La Fuente M. Changes in the macrophage function with aging. Comp Biochem Physiol A Comp Physiol (1985) 81(4):935-8. doi:10.1016/0300-9629(85)90933-8
41. Fietta A, Merlini C, De Bernardi PM, Gandola L, Piccioni PD, Grassi C. Non specific immunity in aged healthy subjects and in patients with chronic bronchitis. Aging (Milano) (1993) 5(5):357-61
42. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell (2004) 3(4):161-7. doi:10.1111/j.1474-9728.2004.00102.x
43. Herrero C, Marques L, Lloberas J, Celada A. IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J Clin Invest (2001) 107(4):485-93. doi:10.1172/JCI11696
44. Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol (2004) 75(2):342-9. doi:10.1189/jlb.0803389
45. Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ. Aging negatively skews macrophage TLR2-and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev (2005) 126(12):1305-13. doi:10.1016/j.mad.2005.07.009
46. Montgomery RR, Shaw AC. Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol (2015) 98(6):937-43. doi:10.1189/jlb.5MR0315-104R
47. Nyugen J, Agrawal S, Gollapudi S, Gupta S. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol (2010) 30(6):806-13. doi:10.1007/s10875-010-9448-8
48. van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, et al. Age-associated defect in human TLR-1/2 function. J Immunol (2007) 178(2):970-5. doi:10.4049/jimmunol.178.2.970
49. Agius E, Lacy KE, Vukmanovic-Stejic M, Jagger AL, Papageorgiou AP, Hall S, et al. Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med (2009) 206(9):1929-40. doi:10.1084/jem.20090896
50. Molony RD, Nguyen JT, Kong Y, Montgomery RR, Shaw AC, Iwasaki A. Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes. Sci Signal (2017) 10(509):eaan2392. doi:10.1126/scisignal.aan2392
51. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F. Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunol (2010) 11:30. doi:10.1186/1471-2172-11-30
52. Chara L, Sanchez-Atrio A, Perez A, Cuende E, Albarran F, Turrion A, et al. Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis. Arthritis Res Ther (2012) 14(4):R175. doi:10.1186/ar3928
53. Xia L, Lu J, Xiao W. Blockage of TNF-alpha by infliximab reduces CCL2 and CCR2 levels in patients with rheumatoid arthritis. J Investig Med (2011) 59(6):961-3. doi:10.2310/JIM.0b013e31821c0242
54. Arnardottir HH, Dalli J, Colas RA, Shinohara M, Serhan CN. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines. J Immunol (2014) 193(8):4235-44. doi:10.4049/jimmunol.1401313
55. Albright JW, Albright JF. Ageing alters the competence of the immune system to control parasitic infection. Immunol Lett (1994) 40(3):279-85. doi:10.1016/0165-2478(94)00066-2
56. Bradley SF, Kauffman CA. Aging and the response to Salmonella infection. Exp Gerontol (1990) 25(1):75-80. doi:10.1016/0531-5565(90)90012-Q
57. Aprahamian T, Takemura Y, Goukassian D, Walsh K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol (2008) 152(3):448-55. doi:10.1111/j.1365-2249.2008.03658.x
58. Njie EG, Boelen E, Stassen FR, Steinbusch HW, Borchelt DR, Streit WJ. Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging (2012) 33(1):195.e1-12. doi:10.1016/j.neurobiolaging.2010.05.008
59. Swift ME, Burns AL, Gray KL, DiPietro LA. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol (2001) 117(5):1027-35. doi:10.1046/j.0022-202x.2001.01539.x
60. Johnson SA, Rozzo SJ, Cambier JC. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol (2002) 168(10):5014-23. doi:10.4049/jimmunol.168.10.5014
61. Riley RL. Impaired B lymphopoiesis in old age: a role for inflammatory B cells? Immunol Res (2013) 57(1-3):361-9. doi:10.1007/s12026-013-8444-5
62. Berent-Maoz B, Montecino-Rodriguez E, Dorshkind K. Genetic regulation of thymocyte progenitor aging. Semin Immunol (2012) 24(5):303-8. doi:10.1016/j.smim.2012.04.006
63. Min H, Montecino-Rodriguez E, Dorshkind K. Effects of aging on early B-and T-cell development. Immunol Rev (2005) 205:7-17. doi:10.1111/j.0105-2896.2005.00263.x
64. Nikolich-Zugich J. Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories. J Immunol (2014) 193(6):2622-9. doi:10.4049/jimmunol.1401174
65. Geiger H, de Haan G, Florian MC. The ageing haematopoietic stem cell compartment. Nat Rev Immunol (2013) 13(5):376-89. doi:10.1038/nri3433
66. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med (1996) 2(9):1011-6. doi:10.1038/nm1296-1282
67. Sudo K, Ema H, Morita Y, Nakauchi H. Age-associated characteristics of murine hematopoietic stem cells. J Exp Med (2000) 192(9):1273-80. doi:10.1084/jem.192.9.1273
68. Miller JP, Allman D. Linking age-related defects in B lymphopoiesis to the aging of hematopoietic stem cells. Semin Immunol (2005) 17(5):321-9. doi:10.1016/j.smim.2005.05.003
69. Shimazu T, Iida R, Zhang Q, Welner RS, Medina KL, Alberola-Lla J, et al. CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential. Blood (2012) 119(21):4889-97. doi:10.1182/blood-2011-10-388736
70. Ergen AV, Boles NC, Goodell MA. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood (2012) 119(11):2500-9. doi:10.1182/blood-2011-11-391730
71. Labrie JE III, Sah AP, Allman DM, Cancro MP, Gerstein RM. Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J Exp Med (2004) 200(4):411-23. doi:10.1084/jem.20040845
72. Palmer DB. The effect of age on thymic function. Front Immunol (2013) 4:316. doi:10.3389/fimmu.2013.00316
73. McKenna RW, Washington LT, Aquino DB, Picker LJ, Kroft SH. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood (2001) 98(8):2498-507. doi:10.1182/blood. V98.8.2498
74. Rossi MID, Yokota T, Medina KL, Garrett KP, Comp PC, Schipul AH, et al. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood (2003) 101(2):576-84. doi:10.1182/blood-2002-03-0896
75. Alter-Wolf S, Blomberg BB, Riley RL. Deviation of the B cell pathway in senescent mice is associated with reduced surrogate light chain expression and altered immature B cell generation, phenotype, and light chain expression. J Immunol (2009) 182(1):138-47. doi:10.4049/jimmunol.182.1.138
76. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood (1998) 91(1):75-88
77. Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM. Naive T cell maintenance and function in human aging. J Immunol (2015) 194(9):4073-80. doi:10.4049/jimmunol.1500046
78. Weksler ME, Szabo P. The effect of age on the B-cell repertoire. J Clin Immunol (2000) 20(4):240-9. doi:10.1023/A:1006659401385
79. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood (1993) 82(9):2767-73
80. Mattoo H, Faulkner M, Kandpal U, Das R, Lewis V, George A, et al. Naive CD4 T cells from aged mice show enhanced death upon primary activation. Int Immunol (2009) 21(11):1277-89. doi:10.1093/intimm/dxp094
81. van der Geest KS, Abdulahad WH, Tete SM, Lorencetti PG, Horst G, Bos NA, et al. Aging disturbs the balance between effector and regulatory CD4+ T cells. Exp Gerontol (2014) 60:190-6. doi:10.1016/j.exger.2014.11.005
82. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production. Clin Exp Immunol (2000) 119(3):433-40. doi:10.1046/j.1365-2249.2000.01146.x
83. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol (1998) 160(4):1627-37
84. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol (1999) 162(4):2154-61
85. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 190(7):1013-24. doi:10.1084/jem.190.7.1013
86. Lefebvre JS, Maue AC, Eaton SM, Lanthier PA, Tighe M, Haynes L. The aged microenvironment contributes to the age-related functional defects of CD4 T cells in mice. Aging Cell (2012) 11(5):732-40. doi:10.1111/j.1474-9726.2012.00836.x
87. Maue AC, Eaton SM, Lanthier PA, Sweet KB, Blumerman SL, Haynes L. Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J Immunol (2009) 182(10):6129-35. doi:10.4049/jimmunol.0804226
88. Lefebvre JS, Masters AR, Hopkins JW, Haynes L. Age-related impairment of humoral response to influenza is associated with changes in antigen specific T follicular helper cell responses. Sci Rep (2016) 6:25051. doi:10.1038/srep25051
89. Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, Hildeman DA, et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol (2008) 181(3):1835-48. doi:10.4049/jimmunol.181.3.1835
90. Raynor J, Karns R, Almanan M, Li KP, Divanovic S, Chougnet CA, et al. IL-6 and ICOS antagonize Bim and promote regulatory T cell accrual with age. J Immunol (2015) 195(3):944-52. doi:10.4049/jimmunol.1500443
91. Huang MC, Liao JJ, Bonasera S, Longo DL, Goetzl EJ. Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J (2008) 22(7):2142-50. doi:10.1096/fj.07-103721
92. Rosenkranz D, Weyer S, Tolosa E, Gaenslen A, Berg D, Leyhe T, et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol (2007) 188(1-2):117-27. doi:10.1016/j.jneuroim.2007.05.011
93. Hwang KA, Kim HR, Kang I. Aging and human CD4(+) regulatory T cells. Mech Ageing Dev (2009) 130(8):509-17. doi:10.1016/j.mad.2009.06.003
94. Hogan T, Gossel G, Yates AJ, Seddon B. Temporal fate mapping reveals age-linked heterogeneity in naive T lymphocytes in mice. Proc Natl Acad Sci U S A (2015) 112(50):E6917-26. doi:10.1073/pnas.1517246112
95. Wallace DL, Zhang Y, Ghattas H, Worth A, Irvine A, Bennett AR, et al. Direct measurement of T cell subset kinetics in vivo in elderly men and women. J Immunol (2004) 173(3):1787-94. doi:10.4049/jimmunol.173.3.1787
96. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, et al. The influence of age on T cell generation and TCR diversity. J Immunol (2005) 174(11):7446-52. doi:10.4049/jimmunol.174.11.7446
97. Kassiotis G, Zamoyska R, Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J Exp Med (2003) 197(8):1007-16. doi:10.1084/jem.20021812
98. Kieper WC, Burghardt JT, Surh CD. A role for TCR affinity in regulating naive T cell homeostasis. J Immunol (2004) 172(1):40-4. doi:10.4049/jimmunol.172.1.40
99. Rudd BD, Venturi V, Li G, Samadder P, Ertelt JM, Way SS, et al. Nonrandom attrition of the naive CD8+ T-cell pool with aging governed by T-cell receptor:pMHC interactions. Proc Natl Acad Sci U S A (2011) 108(33):13694-9. doi:10.1073/pnas.1107594108
100. Weng NP. Aging of the immune system: how much can the adaptive immune system adapt? Immunity (2006) 24(5):495-9. doi:10.1016/j.immuni.2006.05.001
101. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol (2004) 5(2):133-9. doi:10.1038/ni1033
102. Johnson SA, Cambier JC. Ageing, autoimmunity and arthritis: senescence of the B cell compartment-implications for humoral immunity. Arthritis Res Ther (2004) 6(4):131-9. doi:10.1186/ar1180
103. Frasca D, Landin AM, Riley RL, Blomberg BB. Mechanisms for decreased function of B cells in aged mice and humans. J Immunol (2008) 180(5):2741-6. doi:10.4049/jimmunol.180.5.2741
104. Gibson KL, Wu YC, Barnett Y, Duggan O, Vaughan R, Kondeatis E, et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell (2009) 8(1):18-25. doi:10.1111/j.1474-9726.2008.00443.x
105. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol (2002) 37(2-3):427-39. doi:10.1016/S0531-5565(01)00210-8
106. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol (1993) 150(2):543-9
107. Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol (2008) 180(8):5283-90. doi:10.4049/jimmunol.180.8.5283
108. Speziali E, Santiago AF, Fernandes RM, Vaz NM, Menezes JS, Faria AM. Specific immune responses but not basal functions of B and T cells are impaired in aged mice. Cell Immunol (2009) 256(1-2):1-5. doi:10.1016/j.cellimm.2009.01.010
109. Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev (1997) 160:63-77. doi:10.1111/j.1600-065X.1997.tb01028.x
110. Frasca D, Van der Put E, Riley RL, Blomberg BB. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol (2004) 172(4):2155-62. doi:10.4049/jimmunol.172.4.2155
111. Whisler RL, Grants IS. Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. Mech Ageing Dev (1993) 71(1-2):31-46. doi:10.1016/0047-6374(93)90033-N
112. Dailey RW, Eun SY, Russell CE, Vogel LA. B cells of aged mice show decreased expansion in response to antigen, but are normal in effector function. Cell Immunol (2001) 214(2):99-109. doi:10.1006/cimm.2001.1894
113. Frasca D, Riley RL, Blomberg BB. Effect of age on the immunoglobulin class switch. Crit Rev Immunol (2004) 24(5):297-320. doi:10.1615/CritRevImmunol.v24.i5.10
114. Frasca D, Van der Put E, Landin AM, Gong D, Riley RL, Blomberg BB. RNA stability of the E2A-encoded transcription factor E47 is lower in splenic activated B cells from aged mice. J Immunol (2005) 175(10):6633-44. doi:10.4049/jimmunol.175.10.6633
115. Kline GH, Hayden TA, Klinman NR. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol (1999) 162(6):3342-9
116. Klinman NR, Kline GH. The B-cell biology of aging. Immunol Rev (1997) 160:103-14. doi:10.1111/j.1600-065X.1997.tb01031.x
117. Weksler ME. Changes in the B-cell repertoire with age. Vaccine (2000) 18(16):1624-8. doi:10.1016/S0264-410X(99)00497-1
118. Hao Y, O'Neill P, Naradikian MS, Scholz JL, Cancro MP. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood (2011) 118(5):1294-304. doi:10.1182/blood-2011-01-330530
119. Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for the development of autoimmunity. Blood (2011) 118(5):1305-15. doi:10.1182/blood-2011-01-331462
120. Lee-Chang C, Bodogai M, Moritoh K, Olkhanud PB, Chan AC, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood (2014) 124(9):1450-9. doi:10.1182/blood-2014-03-563940
121. Naradikian MS, Hao Y, Cancro MP. Age-associated B cells: key mediators of both protective and autoreactive humoral responses. Immunol Rev (2016) 269(1):118-29. doi:10.1111/imr.12380
122. Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT. Data correlations between gender, cytomegalovirus infection and T cells, NK cells, and soluble immune mediators in elderly humans. Data Brief (2016) 8:536-44. doi:10.1016/j.dib.2016.06.006
123. Marttila S, Jylhävä J, Nevalainen T, Nykter M, Jylhä M, Hervonen A, et al. Transcriptional analysis reveals gender-specific changes in the aging of the human immune system. PLoS One (2013) 8(6):e66229. doi:10.1371/journal.pone.0066229
124. Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT. The effect of sex on immune cells in healthy aging: elderly women have more robust natural killer lymphocytes than do elderly men. Mech Ageing Dev (2016) 156:25-33. doi:10.1016/j.mad.2016.04.001
125. Yovel G, Shakhar K, Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol (2001) 81(2):254-62. doi:10.1006/gyno.2001.6153
126. Bain BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol (1996) 49(8):664-6. doi:10.1136/jcp.49.8.664
127. Sánchez-Ramón S, Radigan L, Joyce EY, Bard S, Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol (2008) 128(3):314-21. doi:10.1016/j.clim.2008.02.013
128. Warren KJ, Sweeter JM, Pavlik JA, Nelson AJ, Devasure JM, Dickinson JD, et al. Sex differences in activation of lung-related type 2 innate lymphoid cells in experimental asthma. Ann Allergy Asthma Immunol (2017) 118(2):233-4. doi:10.1016/j.anai.2016.11.011
129. Les Laboratoires Servier. Lymphatic system Illustrations (2018) Available from: https://smart.servier.com/(Accessed: March 15, 2018)
130. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol (2016) 16(10):626-38. doi:10.1038/nri.2016.90
131. Traub S, Demaria O, Chasson L, Serra F, Desnues B, Alexopoulou L. Sex bias in susceptibility to MCMV infection: implication of TLR9. PLoS One (2012) 7(9):e45171. doi:10.1371/journal.pone.0045171
132. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science (2006) 312(5780):1669-72. doi:10.1126/science.1124978
133. Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol (2006) 177(4):2088-96. doi:10.4049/jimmunol.177.4.2088
134. Da Silva JA. Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Ann Rheum Dis (1995) 54(1):6-16. doi:10.1136/ard.54.1.6
135. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol (2008) 8(9):737-44. doi:10.1038/nri2394
136. Spitzer JA. Gender differences in some host defense mechanisms. Lupus (1999) 8(5):380-3. doi:10.1177/096120339900800510
137. Mondal S, Rai U. Sexual dimorphism in phagocytic activity of wall lizard's splenic macrophages and its control by sex steroids. Gen Comp Endocrinol (1999) 116(2):291-8. doi:10.1006/gcen.1999.7370
138. Weinstein Y, Ran S, Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J Immunol (1984) 132(2):656-61
139. Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiebaut R, et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A (2014) 111(2):869-74. doi:10.1073/pnas.1321060111
140. Deguchi K, Kamada M, Irahara M, Maegawa M, Yamamoto S, Ohmoto Y, et al. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause (2001) 8(4):266-73. doi:10.1097/00042192-200107000-00008
141. Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol (2004) 63(1):31-8. doi:10.1016/j.jri.2004.02.001
142. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, Ceda GP, et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab (2006) 91(1):345-7. doi:10.1210/jc.2005-1097
143. Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos 2012. CA Cancer J Clin (2012) 62:10-29. doi:10.3322/caac.21153
144. Butterworth M, McClellan B, Allansmith M. Influence of sex in immunoglobulin levels. Nature (1967) 214(5094):1224-5. doi:10.1038/2141224a0
145. Klein SL, Huber S. Sex differences in susceptibility to viral infection. In: Klein SL, Roberts CW, editors. Sex Hormones and Immunity to Infection. Berlin: Springer-Verlag (2009) 93-122
146. Cook IF. Sexual dimorphism of humoral immunity with human vaccines. Vaccine (2008) 26(29-30):3551-5. doi:10.1016/j.vaccine.2008.04.054
147. Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis (2010) 10(5):338-49. doi:10.1016/S1473-3099(10)70049-9
148. Wikby A, Mansson IA, Johansson B, Strindhall J, Nilsson SE. The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology (2008) 9(5):299-308. doi:10.1007/s10522-008-9138-6
149. Villacres MC, Longmate J, Auge C, Diamond DJ. Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion. Hum Immunol (2004) 65(5):476-85. doi:10.1016/j.humimm.2004.02.021
150. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 1(12):1279-83. doi:10.1038/nm1295-1279
151. Das BR, Bhanushali AA, Khadapkar R, Jeswani KD, Bhavsar M, Dasgupta A. Reference ranges for lymphocyte subsets in adults from western India: influence of sex, age and method of enumeration. Indian J Med Sci (2008) 62(10):397-406. doi:10.4103/0019-5359.42725
152. Strindhall J, Skog M, Ernerudh J, Bengner M, Lofgren S, Matussek A, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) (2013) 35(3):985-91. doi:10.1007/s11357-012-9400-3
153. Lee OJ, Cho YN, Kee SJ, Kim MJ, Jin HM, Lee SJ, et al. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults. Exp Gerontol (2014) 49:47-54. doi:10.1016/j.exger.2013.11.003
154. Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T. Slower immune system aging in women versus men in the Japanese population. Immun Ageing (2013) 10(1):19. doi:10.1186/1742-4933-10-19
155. Kovats S, Carreras E, Agrawal H. Sex steroid receptors in immune cells. In: Klein SL, Roberts CW, editors. Sex Hormones and Immunity to Infection. Berlin: Springer-Verlag (2010) 53-92
156. Perheentupa A, Huhtaniemi I. Aging of the human ovary and testis. Mol Cell Endocrinol (2009) 299(1):2-13. doi:10.1016/j.mce.2008.11.004
157. Bain J. Testosterone and the aging male: to treat or not to treat? Maturitas (2010) 66(1):16-22. doi:10.1016/j.maturitas.2010.01.009
158. Neal-Perry G, Nejat E, Dicken C. The neuroendocrine physiology of female reproductive aging: an update. Maturitas (2010) 67(1):34-8. doi:10.1016/j.maturitas.2010.04.016
159. Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell (2015) 14(3):309-21. doi:10.1111/acel.12326
160. Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, et al. Immune cell circulating subsets are affected by gonadal function. Life Sci (1994) 54(18):1305-12. doi:10.1016/0024-3205(94)00508-7
161. Kamada M, Irahara M, Maegawa M, Yasui T, Yamano S, Yamada M, et al. B cell subsets in postmenopausal women and the effect of hormone replacement therapy. Maturitas (2001) 37(3):173-9. doi:10.1016/S0378-5122(00)00180-8
162. Rais M, Wilson RM, Urbanski HF, Messaoudi I. Androgen supplementation improves some but not all aspects of immune senescence in aged male macaques. GeroScience (2017) 39:373-84. doi:10.1007/s11357-017-9979-5
163. Elderman M, Sovran B, Hugenholtz F, Graversen K, Huijskes M, Houtsma E, et al. The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice. PLoS One (2017) 12(9):e0184274. doi:10.1371/journal.pone.0184274
164. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science (2013) 339(6123):1084-8. doi:10.1126/science.1233521
165. Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, et al. Intestinal microbiota is influenced by gender and body mass index. PLoS One (2016) 11(5):e0154090. doi:10.1371/journal.pone.0154090
166. Singh P, Manning SD. Impact of age and sex on the composition and abundance of the intestinal microbiota in individuals with and without enteric infections. Ann Epidemiol (2016) 26(5):380-5. doi:10.1016/j.annepidem.2016.03.007
167. Kozik AJ, Nakatsu CH, Chun H, Jones-Hall YL. Age, sex, and TNF associated differences in the gut microbiota of mice and their impact on acute TNBS colitis. Exp Mol Pathol (2017) 103(3):311-9. doi:10.1016/j.yexmp.2017.11.014
168. Yurkovetskiy L, Burrows M, Khan AA, Graham L, Volchkov P, Becker L, et al. Gender bias in autoimmunity is influenced by microbiota. Immunity (2013) 39(2):400-12. doi:10.1016/j.immuni.2013.08.013
169. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell (2014) 157(1):121-41. doi:10.1016/j.cell.2014.03.011
170. Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell (2018) 33(4):570-80. doi:10.1016/j.ccell.2018.03.015
171. Gomez A, Luckey D, Taneja V. The gut microbiome in autoimmunity: sex matters. Clin Immunol (2015) 159(2):154-62. doi:10.1016/j.clim.2015.04.016
172. Bolnick DI, Snowberg LK, Hirsch PE, Lauber CL, Org E, Parks B, et al. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nat Commun (2014) 5:4500. doi:10.1038/ncomms5500
173. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 72(2):1027-33. doi:10.1128/AEM.72.2.1027-1033.2006
174. Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis (2009) 200(2):172-80. doi:10.1086/599790
175. Brandão AP, De Oliveira TC, de Cunto Brandileone MC, Gonçalves JE, Yara TI, Simonsen V. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil. Vaccine (2004) 23(6):762-8. doi:10.1016/j.vaccine.2004.07.024
176. Goldblatt D, Southern J, Andrews N, Ashton L, Burbidge P, Woodgate S, et al. The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Clin Infecti Dis (2009) 49(9):1318-25. doi:10.1086/606046
177. Hainz U, Jenewein B, Asch E, Pfeiffer K-P, Berger P, Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine (2005) 23(25):3232-5. doi:10.1016/j.vaccine.2005.01.085
178. Stark K, Schönfeld C, Barg J, Molz B, Vornwald A, Bienzle U. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine (1999) 17(7):844-50. doi:10.1016/S0264-410X(98)00269-2
179. Marlovits S, Stocker R, Efstratiou A, Broughton K, Kaider A, Vecsei V, et al. Effect on diphtheria immunity of combined tetanus and diphtheria booster vaccination in adults. Eur J Clin Microbiol Infect Dis (2000) 19(7):506-13. doi:10.1007/s100960000305
180. Cook IF. Sex differences in injection site reactions with human vaccines. Hum Vaccin (2009) 5(7):441-9. doi:10.4161/hv.8476
181. Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, et al. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med (1996) 156(14):1546-50. doi:10.1001/archinte.1996.00440130090009
182. Govaert T, Dinant G, Aretz K, Masurel N, Sprenger M, Knottnerus J. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ (1993) 307(6910):988-90. doi:10.1136/bmj.307.6910.988
183. Honkanen PO, Keistinen T, Kivelä S-L. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med (1996) 156(2):205-8. doi:10.1001/archinte.1996.00440020115015
184. Donalisio MR, Ramalheira RM, Cordeiro R. Eventos adversos após vacinação contra influenza em idosos, Distrito de Campinas, SP, 2000. Rev Soc Bras Med Trop (2003) 36(4):467-71. doi:10.1590/S0037-86822003000400006
185. Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine (2007) 25(44):7656-63. doi:10.1016/j.vaccine.2007.08.042
186. Beyer WP, Palache A, Kerstens R, Masurel N. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis (1996) 15(1):65-70. doi:10.1007/BF01586187
187. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang C-Y, Cox NJ, et al. Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med (2008) 168(22):2405-14. doi:10.1001/archinternmed.2008.513
188. Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine (2001) 19(32):4703-9. doi:10.1016/S0264-410X(01)00225-0
189. Cook IF, Pond D, Hartel G. Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults. Vaccine (2007) 25(25):4767-74. doi:10.1016/j.vaccine.2007.04.017
190. Socan M, Frelih T, Janet E, Petraš T, Peternelj B. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine. Vaccine (2004) 22(23):3087-91. doi:10.1016/j.vaccine.2004.02.003
191. Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005-2009. J Infect (2015) 70(2):178-86. doi:10.1016/j.jinf.2014.08.018
192. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 332(12):761-7. doi:10.1056/NEJM199503233321201
193. White W, Barnes G, Barker E, Gall D, Knight P, Griffith A, et al. Reactions to tetanus toxoid. J Hyg (Lond) (1973) 71(02):283-97. doi:10.1017/S0022172400022750
194. Bayas J, Vilella A, Bertran M, Vidal J, Batalla J, Asenjo M, et al. Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary? Epidemiol Infect (2001) 127(03):451-60. doi:10.1017/S095026880100629X
195. Weinberg GA, Szilagyi PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis (2010) 201(11):1607-10. doi:10.1086/652404
196. Wang CS, Wang ST, Chou P. Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine (2002) 20(19-20):2494-9. doi:10.1016/S0264-410X(02)00181-0
197. Vila-Córcoles A, Rodriguez T, de Diego C, Ochoa O, Valdivieso A, Salsench E, et al. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods. Vaccine (2007) 25(37):6699-707. doi:10.1016/j.vaccine.2007.07.015
198. Fleming D, Watson J, Nicholas S, Smith G, Swan A. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect (1995) 115(3):581-9. doi:10.1017/S095026880005874X
199. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med (2007) 357(14):1373-81. doi:10.1056/NEJMoa070844
200. Nichol K, Margolis K, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med (1994) 331(12):778-84. doi:10.1056/NEJM199409223311206
201. Soneji S, Metlay J. Mortality reductions for older adults differ by race/ethnicity and gender since the introduction of adult and pediatric pneumococcal vaccines. Public Health Rep (2011) 126(2):259. doi:10.1177/003335491112600217
202. Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, et al. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine (2014) 32(19):2198-203. doi:10.1016/j.vaccine.2014.02.048
203. Vadasz Z, Haj T, Kessel A, Toubi E. Age-related autoimmunity. BMC Med (2013) 11:94. doi:10.1186/1741-7015-11-94
204. Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest (2015) 125(6):2228-33. doi:10.1172/JCI78088
205. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev (2003) 2(3):119-25. doi:10.1016/S1568-9972(03)00006-5
206. Kotzin BL. Systemic lupus erythematosus. Cell (1996) 85(3):303-6. doi:10.1016/S0092-8674(00)81108-3
207. Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, et al. Demographic and clinical features of neuromyelitis optica: a review. Mult Scler (2015) 21(7):845-53. doi:10.1177/1352458515572406
208. Quek AM, McKeon A, Lennon VA, Mandrekar JN, Iorio R, Jiao Y, et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol (2012) 69(8):1039-43. doi:10.1001/archneurol.2012.249
209. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA Jr. Incidence of systemic sclerosis in Allegheny county, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum (1997) 40(3):441-5. doi:10.1002/art.1780400309
210. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 111(1):87-98. doi:10.1093/oxfordjournals.aje.a112878
211. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med (2014) 371(17):1653. doi:10.1056/NEJMcp1214825
212. Ostan R, Monti D, Gueresi P, Bussolotto M, Franceschi C, Baggio G. Gender, aging and longevity in humans: an update of an intriguing/neglected scenario paving the way to a gender-specific medicine. Clin Sci (Lond) (2016) 130(19):1711-25. doi:10.1042/CS20160004
213. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med (2003) 34(5):546-52. doi:10.1016/S0891-5849(02)01356-4
214. Vina J, Borras C, Gambini J, Sastre J, Pallardo FV. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett (2005) 579(12):2541-5. doi:10.1016/j.febslet.2005.03.090
215. Engelmann F, Rivera A, Park B, Messerle-Forbes M, Jensen JT, Messaoudi I. Impact of estrogen therapy on lymphocyte homeostasis and the response to seasonal influenza vaccine in post-menopausal women. PLoS One (2016) 11(2):e0149045. doi:10.1371/journal.pone.0149045
216. Zhang J, Chen X, Zhang S, Zhou G, Xia X, Lu L. Effects of transdermal estrogen therapy on expressions of estrogen receptors and T-lymphocyte apoptosis in surgically menopausal women. Cell Mol Immunol (2009) 6(4):277-83. doi:10.1038/cmi.2009.37
217. Schulze-Koops H. Lymphopenia and autoimmune diseases. Arthritis Res Ther (2004) 6(4):178-80. doi:10.1186/ar1208
218. Viguier M, Fouere S, de la Salmoniere P, Rabian C, Lebbe C, Dubertret L, et al. Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Baltimore) (2003) 82(2):82-6. doi:10.1097/00005792-200303000-00002
219. Iannone F, Cauli A, Yanni G, Kingsley GH, Isenberg DA, Corrigall V, et al. T-lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br J Rheumatol (1996) 35(9):839-45. doi:10.1093/rheumatology/35.9.839
220. Kirtava Z, Blomberg J, Bredberg A, Henriksson G, Jacobsson L, Manthorpe R. CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjogren's syndrome. Clin Exp Rheumatol (1995) 13(5):609-16
221. Mandl T, Bredberg A, Jacobsson LT, Manthorpe R, Henriksson G. CD4+ T-lymphocytopenia-a frequent finding in anti-SSA antibody seropositive patients with primary Sjogren's syndrome. J Rheumatol (2004) 31(4):726-8
222. Kaaba SA, Al-Harbi SA. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives. Immunol Lett (1995) 47(3):209-13. doi:10.1016/0165-2478(95)00088-5
223. Brandt L, Stenstam M. Letter: subnormal lymphocyte-counts in adult coeliac disease. Lancet (1975) 1(7913):978-9. doi:10.1016/S0140-6736(75)92041-3
224. Heimann TM, Bolnick K, Aufses AH Jr. Prognostic significance of severe preoperative lymphopenia in patients with Crohn's disease. Ann Surg (1986) 203(2):132-5. doi:10.1097/00000658-198602000-00004
225. Goronzy JJ, Li G, Yang Z, Weyand CM. The Janus head of T cell aging-autoimmunity and immunodeficiency. Front Immunol (2013) 4:131. doi:10.3389/fimmu.2013.00131
226. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 97(16):9203-8. doi:10.1073/pnas.97.16.9203
227. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 95(24):14447-52. doi:10.1073/pnas.95.24.14447
228. Shao L, Fujii H, Colmegna I, Oishi H, Goronzy JJ, Weyand CM. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med (2009) 206(6):1435-49. doi:10.1084/jem.20082251
229. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum (1997) 40(6):1106-14. doi:10.1002/art.1780400615
230. Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2004) 50(1):43-54. doi:10.1002/art.11445
231. Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl-Ulrich K, Seitzer U, et al. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol (2002) 160(5):1717-24. doi:10.1016/S0002-9440(10)61118-2
232. McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DR, Willcocks LC, et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med (2010) 16(5):586-91. doi:10.1038/nm.2130
233. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin (2009) 59(4):225-49. doi:10.3322/caac.20006
234. Kanapuru B, Posani K, Muller D, Ershler WB. Decreased cancer prevalence in the nursing home. J Am Geriatr Soc (2008) 56(11). doi:10.1111/j.1532-5415.2008.01864.x
235. Stanta G, Campagner L, Cavalieri F, Giarelli L. Cancer of the oldest old-what we have learned from autopsy studies. Clin Geriatr Med (1997) 13(1):55
236. Ershler WB, Longo DL. Aging and cancer: issues of basic and clinical science. J Natl Cancer Inst (1997) 89(20):1489-97. doi:10.1093/jnci/89.20.1489
237. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst (2000) 92(7):550-6. doi:10.1093/jnci/92.7.550
238. Jedroszka D, Orzechowska M, Hamouz R, Gorniak K, Bednarek AK. Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer. PLoS One (2017) 12(12):e0188842. doi:10.1371/journal.pone.0188842
239. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int (2010) 105(3):300-8. doi:10.1111/j.1464-410X.2009.09076.x
240. Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet (2013) 381(9865):484-95. doi:10.1016/S0140-6736(12)61727-9
241. Chian CF, Hwang YT, Terng HJ, Lee SC, Chao TY, Chang H, et al. Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages. Oncotarget (2016) 7(31):50582-95. doi:10.18632/oncotarget.10558
242. Snaebjornsson P, Jonasson L, Jonsson T, Moller PH, Theodors A, Jonasson JG. Colon cancer in Iceland-a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer (2010) 127(11):2645-53. doi:10.1002/ijc.25258
243. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev (2009) 18(4):1174-82. doi:10.1158/1055-9965.EPI-08-1118
244. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 20(8):1629-37. doi:10.1158/1055-9965.EPI-11-0246
245. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin (2018) 68(1):7-30. doi:10.3322/caac.21442
246. Purim O, Gordon N, Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit (2013) 19:203-9. doi:10.12659/MSM.883842
247. Yang Y, Li T, Nielsen ME. Aging and cancer mortality: dynamics of change and sex differences. Exp Gerontol (2012) 47(9):695-705. doi:10.1016/j.exger.2012.06.009
248. Yang Y, Kozloski M. Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci (2011) 66(5):493-500. doi:10.1093/gerona/glr003
249. Barzi A, Lenz AM, Labonte MJ, Lenz HJ. Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res (2013) 19(21):5842-8. doi:10.1158/1078-0432.CCR-13-0325
250. Caiazza F, Ryan EJ, Doherty G, Winter DC, Sheahan K. Estrogen receptors and their implications in colorectal carcinogenesis. Front Oncol (2015) 5:19. doi:10.3389/fonc.2015.00019
251. DePinho RA. The age of cancer. Nature (2000) 408(6809):248-54. doi:10.1038/35041694
252. de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol (2009) 70(3):183-94. doi:10.1016/j.critrevonc.2008.07.021
253. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta-and JNK1-dependent inflammation. Cancer Cell (2010) 17(1):89-97. doi:10.1016/j.ccr.2009.12.008
254. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell (2010) 140(2):197-208. doi:10.1016/j.cell.2009.12.052
255. Khasawneh J, Schulz MD, Walch A, Rozman J, Hrabe de Angelis M, Klingenspor M, et al. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A (2009) 106(9):3354-9. doi:10.1073/pnas.0802864106
256. Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol (2010) 28(26):4086-93. doi:10.1200/JCO.2009.27.0579
257. Mirandola L, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, et al. Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium. Int Rev Immunol (2015) 34(2):134-42. doi:10.3109/08830185.2015.1018417
258. Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med (2015) 373(19):1803-13. doi:10.1056/NEJMoa1510665
259. Hodi FS. Improved survival with ipilimumab in patients with metastatic melanoma (vol 363, pg 711, 2010). N Engl J Med (2010) 363(13):1290. doi:10.1056/NEJMx100063
260. Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med (2015) 372(4):320-30. doi:10.1056/NEJMoa1412082
261. Rosenberg JE, Hoffman-Censits J, Powles T, van der Heijden MS, Balar AV, Necchi A, et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet (2016) 387(10031):1909-20. doi:10.1016/S0140-6736(16)00561-4
262. Lin PY, Sun LS, Thibodeaux SR, Ludwig SM, Vadlamudi RK, Hurez VJ, et al. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. J Immunol (2010) 185(5):2747-53. doi:10.4049/jimmunol.1000496
263. Patel J, Crawford JM. Microbiota-regulated outcomes of human cancer immunotherapy via the PD-1/PD-L1 axis. Biochemistry (2018) 57(6):901-3. doi:10.1021/acs.biochem.7b01249
264. Nishijima TF, Muss HB, Shachar SS, Moschos SJ. Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis. Cancer Treat Rev (2016) 45:30-7. doi:10.1016/j.ctrv.2016.02.006
265. Ferrara R, Mezquita L, Auclin E, Chaput N, Besse B. Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: does age really matter? Cancer Treat Rev (2017) 60:60-8. doi:10.1016/j.ctrv.2017.08.003
266. Landre T, Taleb C, Nicolas P, Guetz GD. Is there a clinical benefit of anti-PD-1 in patients older than 75 years with previously treated solid tumour? J Clin Oncol (2016) 34(15):3070. doi:10.1200/JCO.2016.34.15_suppl.3070
267. Champiat S, Dercle L, Ammari S, Massard C, Hollebecque A, Postel-Vinay S, et al. Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1. Clin Cancer Res (2017) 23(8):1920-8. doi:10.1158/1078-0432.CCR-16-1741
268. Bouchlaka MN, Murphy WJ. Impact of aging in cancer immunotherapy the importance of using accurate preclinical models. Oncoimmunology (2013) 2(12):e27186. doi:10.4161/onci.27186
269. Clayton JA. Applying the new SABV (sex as a biological variable) policy to research and clinical care. Physiol Behav (2018) 187:2-5. doi:10.1016/j.physbeh.2017.08.012